Booster immunization with a fractional dose of Prevnar 13 affects cell-mediated immune response but not humoral immunity in CD-1 mice
Catalioto, Rose-Marie, Valenti, Claudio, Bellucci, Francesca, Cialdai, Cecilia, Altamura, Maria, Digilio, Laura, Pellacani, Andrea Ugo Enrico, Meini, Stefania
Published in Heliyon (01.06.2021)
Published in Heliyon (01.06.2021)
Get full text
Journal Article
Updated results from DIAMOND-01 (CLI24-001) trial: A phase I/II study of SEL24/MEN1703, a first-in-class dual PIM/FLT3 kinase inhibitor, in acute myeloid leukemia
Solomon, Scott R., Montesinos, Pau, Nazha, Aziz, Strickland, Stephen Anthony, Martinelli, Giovanni, Santoro, Armando, Walter, Roland B., Cook, Rachel J., Calbacho, Maria, Vives, Susana, Fazal, Salman, Brzózka, Krzysztof, Shamsili, Setareh, Baldini, Simone, Laurent, Dirk, Pellacani, Andrea Ugo Enrico, Ravandi, Farhad
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
CLI24-001: First-in-human study of SEL24/MEN1703, an oral dual PIM/FLT3 kinase inhibitor, in patients with acute myeloid leukemia
Ravandi, Farhad, Strickland, Stephen Anthony, Solomon, Scott R., Nazha, Aziz, Walter, Roland B., Valimberti, Ilaria, Tagliavini, Alessia, Fiesoli, Caterina, Binaschi, Monica, Brzozka, Krzysztof, Baldini, Simone, Heeger, Steffen, Pellacani, Andrea Ugo
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
CD205, a target antigen for a novel ADC: Evaluation of antigen expression on TNBC, pancreatic adenocarcinoma and bladder urothelial carcinoma
Massa, Simona, Collini, Paola, Spagnuolo, Rosalin Dolores, Bertolotti, Alessia, Garzone, Giovanna, Pruneri, Giancarlo, Carcangiu, Maria Luisa, Kaplan, Angelo, Rohlff, Christian, Buontempo, Serena, Matera, Mariagiuseppa, Bussolo, Vanessa, Merlino, Giuseppe, Binaschi, Monica, Rossi, Cristina, Tonini, Giulia, Fedi, Valentina, Simonelli, Cecilia, Capriati, Angela, Pellacani, Andrea Ugo
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
B-PRECISE-01 Study: A phase Ib trial of MEN1611, a PI3K Inhibitor, combined with trastuzumab ± fulvestrant for the treatment of HER2-positive advanced or metastatic breast cancer
Piccart-Gebhart, Martine J., Aftimos, Philippe Georges, Duhoux, Francois P., Wildiers, Hans, Isambert, Nicolas, Campone, Mario, Tosi, Diego, Varga, Andrea I., Boni, Valentina, Doger, Bernard, Corbacho, Javier Garcia, Jimenez-Rodriguez, Begona, Ruiz Borrego, Manuel, Saura, Cristina, Arkenau, Hendrik-Tobias, Wardley, Andrew M., Troconiz, Inaki F, Binaschi, Monica, Simonelli, Cecilia, Pellacani, Andrea Ugo
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
CD205, a target antigen for a novel antibody drug conjugate (ADC): Evaluation of antigen expression on non-Hodgkin lymphoma (NHL)
Canzonieri, Vincenzo, Gattei, Valter, Spina, Michele, Polizzi-Anselmo, Annalisa, Attanasio, Nickolas, Kaplan, Angelo, Bigioni, Mario, Merlino, Giuseppe, Matera, Mariagiuseppa, Manunta, Silvia, Dusek, Rachel, Rohlff, Christian, Fedi, Valentina, Binaschi, Monica, Pellacani, Andrea Ugo Enrico, Simonelli, Cecilia
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
CD205-Shuttle study: A first-in-human trial of MEN1309/OBT076 an ADC targeting CD205 in solid tumor and NHL
Garralda, Elena, Tabernero, Josep, Moreno Garcia, Victor, De Miguel, Maria José, Plummer, Elizabeth Ruth, Jerusalem, Guy Heinrich Maria, Spina, Michele, Rohlff, Christian, Fandi, Abrahim, Buontempo, Serena, Matera, Mariagiuseppa, Cioce, Mario, Paola, D'Angiolella, Binaschi, Monica, Merlino, Giuseppe, Mazzei, Paolo, Rossi, Cristina, Tonini, Giulia, Simonelli, Cecilia, Pellacani, Andrea Ugo Enrico
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article